Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

समान संसाधन

• Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)
  द्वारा: Strom, Alexander, और अन्य
  प्रकाशित: (2012)
• The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)
  द्वारा: Kolb, Hubert, और अन्य
  प्रकाशित: (2013)
• The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).
  द्वारा: Hubert Kolb, और अन्य
  प्रकाशित: (2013-01-01)
• Type 2 Diabetes Phenotype and Progression Is Significantly Different if Diagnosed before versus after 65 Years of Age
  द्वारा: Hubert Kolb,, और अन्य
  प्रकाशित: (2008)
• Inhaled Insulin: Take a Deep Breath, but How?
  द्वारा: Heinemann, Lutz, और अन्य
  प्रकाशित: (2008)